GondosAS, Al-MoyedKA, Al-RobasiAB, et al.Urinary tract infection among renal transplant recipients in Yemen. PLoS One, 2015; 10:e0144266.
2.
SuiW, LipskyMJ, MatulayJT, et al.Timing and predictors of early urologic and infectious complications after renal transplant: An analysis of a New York statewide database. Exp Clin Transplant, 2018; 16:665–670.
3.
YabanogluH, AliskanHE, CaliskanK, et al.Early infections in renal transplant recipients: Incidence, risk factors, and causative microorganisms. Exp Clin Transplant, 2015; 13(Suppl 3):11–14.
4.
GraversenME, DalgaardLS, Jensen-FangelS, et al.Risk and outcome of pyelonephritis among renal transplant recipients. BMC Infect Dis, 2016; 16:264.
5.
DaskalakiE, KoukoulakiM, BakalisA, et al.Blood stream infections in renal transplant recipients: A single-center study. Transplant Proc, 2014; 46:3191–3193.
6.
KuNS, KimYC, KimMH, et al.Risk factors for 28-day mortality in elderly patients with extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia. Arch Gerontol Geriatr, 2014; 58:105–109.
7.
Perianes-DiazME, Novo-VeleiroI, Solis-DiazK, et al.[Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: Mortality and readmission-related factors] (Spa). Med Clin (Barc), 2014; 142:381–386.
8.
FrakkingFN, RottierWC, Dorigo-ZetsmaJW, et al.Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-beta-lactamase-producing bacteria. Antimicrob Agents Chemother, 2013; 57:3092–3099.
